Kura Oncology, Inc. (NASDAQ:KURA) Given Consensus Recommendation of “Buy” by Analysts
Shares of Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) have been given a consensus rating of “Buy” by the six analysts that are presently covering the firm, Marketbeat reports. Six research analysts have rated the stock with a buy recommendation. The average 12 month price target among brokers that have updated their coverage on […]
More Stories
Spin Master Corp. (OTCMKTS:SNMSF) Announces $0.09 Dividend
Spin Master Corp. (OTCMKTS:SNMSF – Get Free Report) declared a dividend on Saturday, September 21st, investing.com reports. Investors of record...
Middle East crisis: Dramatic uptick in violence in Gaza, Israel and Lebanon
Tensions continued to ratchet up in the Middle East on Monday with reports of hundreds of retaliatory Israeli strikes on...
Baytex Energy Corp. (TSE:BTE) Receives C$6.35 Consensus Price Target from Analysts
Shares of Baytex Energy Corp. (TSE:BTE – Get Free Report) (NYSE:BTE) have earned an average rating of “Moderate Buy” from...
agilon health, inc. (NYSE:AGL) Receives $8.57 Average Price Target from Brokerages
Shares of agilon health, inc. (NYSE:AGL – Get Free Report) have earned an average recommendation of “Hold” from the nineteen...
LyondellBasell Industries (NYSE:LYB) Given Average Recommendation of “Hold” by Brokerages
Shares of LyondellBasell Industries (NYSE:LYB – Get Free Report) have received an average rating of “Hold” from the fifteen ratings...
Brokerages Set Edison International (NYSE:EIX) PT at $84.67
Shares of Edison International (NYSE:EIX – Get Free Report) have been given an average recommendation of “Moderate Buy” by the...